相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2016 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
Beyond Peptides and mAbs-Current Status and Future Perspectives for Biotherapeutics With Novel Constructs
Dalal AlDeghaither et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn
Tianlei Ying et al.
MABS (2015)
Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics
Amita Datta-Mannan et al.
MABS (2015)
Insights into the Impact of Heterogeneous Glycosylation on the Pharmacokinetic Behavior of Follistatin-Fc-Based Biotherapeutics
Amita Datta-Mannan et al.
DRUG METABOLISM AND DISPOSITION (2015)
Human and Non-Human Primate Intestinal FcRn Expression and Immunoglobulin G Transcytosis
Pamela J. Hornby et al.
PHARMACEUTICAL RESEARCH (2014)
A strategy for risk mitigation of antibodies with fast clearance
Isidro Hoetzel et al.
MABS (2012)
Influence of improved FcRn binding on the subcutaneous bioavailability of monoclonal antibodies in cynomolgus monkeys
Amita Datta-Mannan et al.
MABS (2012)
Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions
Jonathan T. Sockolosky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor-α Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
Rong Deng et al.
DRUG METABOLISM AND DISPOSITION (2010)
Therapeutic antibodies: successes, limitations and hopes for the future
Patrick Chames et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells
Koya Sato et al.
LIFE SCIENCES (2009)
Development trends for therapeutic antibody fragments
Aaron L. Nelson et al.
NATURE BIOTECHNOLOGY (2009)
Neonatal Fc Receptor Mediates Internalization of Fc in Transfected Human Endothelial Cells
Nancy A. Goebl et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
Adam R. Mezo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Humanized IgG(1) variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates
Amita Datta-Mannan et al.
DRUG METABOLISM AND DISPOSITION (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin
Allen Nguyen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
From sorting endosomes to exocytosis: Association of Rab4 and Rab11 GTPases with the fc receptor, FcRn, during recycling
ES Ward et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies - African trypanosomes as paradigm
B Stijlemans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
